Follow Us

       


"Like" us on Facebook

Clinical Trials

Cancer - Breast Cancer

Title
EMBRACA. A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation
Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus
MONARCH 1. A Study Of LY2835219 In Participants With Previously Treated Breast Cancer That Has Spread
NALA. A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting
TRIO B-09. Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS Metastasis

Cancer - Heme Malignancies

Title
Ublituximab + Ibrutinib in Select B-cell Malignancies

Cancer - Hodgkin Lymphoma

Title
Phase 3 Frontline Therapy Trial in Patients With Advanced Classical Hodgkin Lymphoma

Cancer - Lung Cancer

Title
A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC
A Safety Trial of Nivolumab (BMS-936558) in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Systemic Regimen
NSCLC diagnosis assay development

Cancer - Melanoma

Title
BRIM8: A Study of Vemurafenib Adjuvant Therapy in Patients With Resected Cutaneous BRAF Mutant Melanoma

Cancer - Multiple Myeloma

Title
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Relapsed/Refractory Multiple Myeloma

Cancer - Non-Hodgkin Lymphoma

Title
Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas
Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas

Cancer - Breast Cancer

Title
Breast Cancer - Novartis (TRIO)

Cancer - GE & Stomach Cancer

Title
GE & Stomach Cancer - MM-111-13-02-04/Merrimack

Cancer - Lung Cancer

Title
NSCLC (Stage IIIB/IV) 2nd Line

Cancer - Multiple Myeloma

Title
Relapsing or progressive disease. Following 1-3 prior regimens

Cancer - Prostate Cancer

Title
Castration and Taxane resistant

Cancer - Breast Cancer

Title
Safety and Efficacy Study of MLN0128 in Combination With Exemestane or Fulvestrant in Postmenopausal Women With ER/PR+ Metastatic Breast Cancer

This is the fat footer - edit page 906 to add content.